[go: up one dir, main page]

Schultz et al., 1998 - Google Patents

TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels

Schultz et al., 1998

View HTML @Full View
Document ID
3842989076267038293
Author
Schultz J
Hsu A
Nagase H
Gross G
Publication year
Publication venue
American Journal of Physiology-Heart and Circulatory Physiology

External Links

Snippet

We have previously shown that delta (δ)-opioid receptors, most notably δ1, are involved in the cardioprotective effect of ischemic preconditioning (PC) in rats; however, the mechanism by which δ-opioid receptor-induced cardioprotection is mediated remains unknown …
Continue reading at journals.physiology.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Similar Documents

Publication Publication Date Title
Schultz et al. TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels
Schultz et al. Ischemic preconditioning in the intact rat heart is mediated by δ1-but not μ-or κ-opioid receptors
Schultz et al. Opioids and cardioprotection
Pugsley The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system
Maslov et al. Prospects for creation of cardioprotective and antiarrhythmic drugs based on opioid receptor agonists
Fryer et al. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium
Tanaka et al. Opioid-induced cardioprotection
Gross Role of opioids in acute and delayed preconditioning
Fryer et al. Essential activation of PKC-δ in opioid-initiated cardioprotection
Wang et al. κ-but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats
Peart et al. Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways
Peart et al. Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors
Schultz et al. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart
Johnson et al. Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions
Wachter et al. Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application
Okubo et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of δ-opioid receptor
Schultz et al. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart
Pepe et al. ‘Cross talk’between opioid peptide and adrenergic receptor signaling in isolated rat heart
Hollenberg et al. Proteinase‐activated receptor‐4: evaluation of tethered ligand‐derived peptides as probes for receptor function and as inflammatory agonists in vivo
Bernstein et al. Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes
JP2001515841A (en) Ischemic disorder reducer
Finley et al. Expression and coassociation of ERG1, KCNQ1, and KCNE1 potassium channel proteins in horse heart
Williams-Pritchard et al. Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning
He et al. Cardiac μ-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure
Paul et al. Pharmacological characterization of nalorphine, a kappa 3 analgesic.